Key result
Intravenous Digoxin increased fractional excretion of magnesium from 3.07% to 7.58% at 60 minutes in patients with rapid atrial fibrillation.
Why the study?
Does intravenous digoxin increase urinary magnesium excretion in subjects with rapid atrial fibrillation?
Observational (n=17)
Does intravenous digoxin increase urinary magnesium excretion in subjects with rapid atrial fibrillation?
Acute intravenous digoxin administration causes significant hypermagnesuria, which correlates with serum digoxin levels and may explain the predisposition to digitalis toxicity associated with hypomagnesemia.
Answers are grounded in this paper and cite their sources.
May promote magnesuria during IV digoxin for rapid AF; hypothesis-generating and leaves open effects on serum levels or supplementation needs.
BACKGROUND: Hypomagnesemia is a known predisposing condition for the appearance of digitalis toxicity. The detection of a genetic form of Mg urinary wasting with hypomagnesemia being caused by a mutation in the γ subunit (FXYD2) of the Na,K-ATPase, the pharmacological target of Digoxin, prompted us to investigate whether Digoxin administration increases urinary Mg excretion. METHODS: Two groups of subjects, with rapid atrial fibrillation, received intravenous Digoxin (n = 9) or verapamil (n = 8), for heart rate control. During the following 4 h, blood and urinary creatinine, sodium, potassium, calcium, and magnesium levels were determined, and fractional excretion (Fex) values for Na, K, Ca, and Mg were calculated. RESULTS: In the Digoxin group, at 60 min Fex Mg rose from 3.07 ± 1.21 to 7.58 ± 2.51% (an increase of 269 ± 107% of baseline, p < 0.001), and at 240 min to 6.05 ± 2.30% (204 ± 56% of baseline, p < 0.01). No significant change was observed for Fex Na, Fex K, and Fex Ca. A striking correlation was found between individual values of Fex Mg and serum Digoxin concentration (r = 0.678, p < 0.0001). No significant correlation was found between Fex Na or Fex K and serum Digoxin. A correlation of borderline significance was found between Fex Ca and serum Digoxin (r = 0.349, p = 0.073). CONCLUSIONS: The hypermagnesuric effect of acute Digoxin treatment is reminiscent of the effect of the missense mutation in FXYD2, which assumes that FXYD2 is a positive regulator of Na,K-ATPase in the distal convoluted tubule (DCT). The borderline calciuric effect of Digoxin may point to an additional site of action, more proximal to the DCT, that is, the thick ascending limb.
No takes yet. Share an insight, caveat, or question.
Abu-Amer et al. (2017) conducted an observational in Rapid atrial fibrillation (n=17). Intravenous Digoxin vs. Verapamil was evaluated on Fractional excretion of magnesium (Fex Mg) at 60 minutes (p=<0.001). Intravenous Digoxin increased fractional excretion of magnesium from 3.07% to 7.58% at 60 minutes in patients with rapid atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: